This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
novel coronavirus | 149 |
emergency department | 117 |
coronavirus disease | 110 |
acute respiratory | 96 |
doc id | 62 |
med doi | 62 |
cord uid | 62 |
emerg med | 62 |
critically ill | 61 |
respiratory syndrome | 61 |
chest compression | 60 |
respiratory failure | 58 |
public health | 53 |
severe acute | 45 |
new york | 43 |
clinical characteristics | 43 |
prone position | 41 |
healthcare workers | 41 |
intensive care | 41 |
mechanical ventilation | 40 |
health care | 39 |
severe cases | 39 |
risk factors | 39 |
cardiac arrest | 39 |
respiratory distress | 38 |
ill patients | 37 |
severe covid | 35 |
endotracheal intubation | 35 |
psychiatric diseases | 34 |
emergency departments | 34 |
clinical features | 34 |
hospitalized patients | 34 |
respiratory support | 33 |
ed visits | 33 |
oxygen saturation | 32 |
case reports | 32 |
cardiopulmonary resuscitation | 32 |
systematic review | 32 |
cohort study | 31 |
nasal cannula | 31 |
protective equipment | 31 |
personal protective | 29 |
chest compressions | 29 |
united states | 29 |
chest ct | 29 |
case report | 27 |
journal pre | 27 |
suspected covid | 27 |
case series | 26 |
airway management | 26 |
york city | 25 |
flow nasal | 25 |
health organization | 23 |
negative rt | 23 |
within hours | 23 |
world health | 23 |
syndrome coronavirus | 23 |
patients presenting | 22 |
heart failure | 22 |
care unit | 22 |
statistically significant | 22 |
health system | 22 |
care workers | 21 |
study period | 21 |
middle east | 20 |
emergency medicine | 20 |
mental status | 20 |
emergency physicians | 20 |
east respiratory | 20 |
confirmed covid | 20 |
clinical improvement | 20 |
disease severity | 20 |
high risk | 19 |
noninvasive ventilation | 19 |
infected pneumonia | 19 |
hypoxemic respiratory | 18 |
distress syndrome | 18 |
may also | 18 |
medical personnel | 18 |
adjudication committee | 17 |
air pollution | 17 |
infectious diseases | 17 |
critical care | 17 |
among patients | 17 |
blood pressure | 17 |
myocardial infarction | 17 |
spontaneous pneumomediastinum | 17 |
disease control | 17 |
retrospective study | 16 |
fatality rate | 16 |
department visits | 16 |
patients infected | 16 |
respiratory rate | 16 |
test positivity | 16 |
clinical course | 16 |
significant difference | 15 |
infection prevention | 15 |
patients admitted | 15 |
respiratory protection | 15 |
reverse cpr | 15 |
sample size | 15 |
social distancing | 15 |
return admission | 15 |
randomized controlled | 15 |
adverse effects | 15 |
qt prolongation | 15 |
pulmonary embolism | 15 |
powered air | 15 |
acute hypoxemic | 15 |
two groups | 15 |
case fatality | 14 |
coronavirus infection | 14 |
ct scan | 14 |
aminoquinoline toxicity | 14 |
diabetes mellitus | 14 |
line therapy | 14 |
annual report | 14 |
control group | 14 |
th rib | 14 |
retrospective cohort | 14 |
daily mean | 14 |
poison control | 14 |
control period | 14 |
chief complaints | 14 |
informed consent | 13 |
mortality among | 13 |
healthcare personnel | 13 |
hospital admissions | 13 |
chief complaint | 13 |
patients requiring | 13 |
fitting papr | 13 |
filtering facepiece | 13 |
clinical trial | 13 |
fit test | 13 |
lung ultrasound | 13 |
reactive protein | 13 |
pcr testing | 13 |
coronavirus pneumonia | 13 |
altered mental | 13 |
factors associated | 13 |
infection control | 12 |
mg kg | 12 |
cardiac injury | 12 |
converting enzyme | 12 |
sonographic findings | 12 |
positivity rate | 12 |
magnesium sulfate | 12 |
chinese medicine | 12 |
increased risk | 12 |
patients may | 12 |
vital signs | 12 |
first case | 12 |
facepiece respirators | 12 |
life support | 12 |
primary outcome | 12 |
plastic blanket | 12 |
invasive ventilation | 12 |
significantly higher | 11 |
fitting paprs | 11 |
american heart | 11 |
acute toxicity | 11 |
real time | 11 |
national poison | 11 |
emergency medical | 11 |
ct findings | 11 |
infectious disease | 11 |
negative conversion | 11 |
observational study | 11 |
used hfnc | 11 |
patient population | 11 |
heart association | 11 |
supine position | 11 |
patients tested | 11 |
admission within | 11 |
latinx patients | 11 |
mental health | 11 |
confidence intervals | 10 |
hospital admission | 10 |
interferon beta | 10 |
icu patients | 10 |
gastrointestinal symptoms | 10 |
heart disease | 10 |
simulation study | 10 |
respiratory tract | 10 |
positive ct | 10 |
per minute | 10 |
infection among | 10 |
air pollutants | 10 |
review board | 10 |
respiratory symptoms | 10 |
hong kong | 10 |
lung injury | 10 |
polymerase chain | 10 |
sars coronavirus | 10 |
medical history | 10 |
pilot study | 10 |
tracheal intubation | 10 |
moderate covid | 10 |
confirmed cases | 10 |
controlled trials | 10 |
cardiac arrests | 10 |
chain reaction | 10 |
hydroxychloroquine overdose | 10 |
severe disease | 10 |
virus disease | 10 |
intubation rate | 10 |
chest pain | 10 |
institutional review | 10 |
least one | 9 |
kidney injury | 9 |
heart rate | 9 |
risk factor | 9 |
oxygen therapy | 9 |
black patients | 9 |
news score | 9 |
high mortality | 9 |
lung zone | 9 |
one study | 9 |
data system | 9 |
used niv | 9 |
hydroxychloroquine toxicity | 9 |
infected patients | 9 |
drug administration | 9 |
national health | 9 |
pass success | 9 |
air embolism | 9 |
per day | 9 |
body mass | 9 |
computed tomography | 9 |
adverse events | 9 |
rescue therapy | 9 |
results showed | 9 |
lung sonographic | 9 |
ischemic stroke | 9 |
may cause | 9 |
healthcare system | 9 |
pao fio | 9 |
renal failure | 9 |
mg dl | 9 |
significant differences | 9 |
previous studies | 9 |
mild disease | 9 |
chloroquine poisoning | 9 |
randomized clinical | 9 |
medical conditions | 9 |
purifying respirators | 9 |
face mask | 9 |
emergency care | 9 |
logistic regression | 9 |
survival cases | 9 |
influenza pandemic | 9 |
poison data | 9 |
medical care | 9 |
data collection | 9 |
continuous variables | 9 |
disease transmission | 9 |
negative pressure | 9 |
medical center | 8 |
patient visits | 8 |
social media | 8 |
symptom onset | 8 |
adverse reactions | 8 |
acute chloroquine | 8 |
clinical practice | 8 |
descriptive study | 8 |
mean age | 8 |
acute kidney | 8 |
pleural line | 8 |
three sessions | 8 |
study population | 8 |
adult inpatients | 8 |
one hour | 8 |
emergency psychiatric | 8 |
study drug | 8 |
lopinavir ritonavir | 8 |
resuscitation council | 8 |
predictive value | 8 |
past medical | 8 |
pain scores | 8 |
american association | 8 |
ed patients | 8 |
emergency cardiovascular | 8 |
lag day | 8 |
ed volumes | 8 |
pcr results | 8 |
clinical status | 8 |
endotracheal tube | 8 |
care ultrasound | 8 |
viral filter | 8 |
total number | 8 |
study group | 8 |
dimer levels | 8 |
exhaled air | 8 |
ambient air | 8 |
baseline characteristics | 8 |
old male | 8 |
abdominal pain | 8 |
prone positioning | 8 |
potassium channels | 8 |
hepa filter | 8 |
median age | 8 |
tested positive | 8 |
controlled trial | 8 |
performed using | 8 |
fit factor | 8 |
medical staff | 8 |
clinical specimens | 8 |
coronavirus sars | 8 |
hospital mortality | 8 |
ethnic disparities | 8 |
previously healthy | 8 |
organ failure | 8 |
pulmonary disease | 8 |
stemi patients | 8 |
first pass | 8 |
induced cardiomyopathy | 8 |
ng ml | 8 |
patients hospitalized | 8 |
respiratory infection | 7 |
mechanism underlying | 7 |
side effects | 7 |
pcr tests | 7 |
blood gas | 7 |
airway pressure | 7 |
patients suspected | 7 |
room air | 7 |
academic research | 7 |
hospital cardiac | 7 |
macintosh laryngoscope | 7 |
diagnostic performance | 7 |
continuous positive | 7 |
failure rate | 7 |
march th | 7 |
convalescent plasma | 7 |
emergency use | 7 |
clinical trials | 7 |
contact tracing | 7 |
niv failure | 7 |
medrxiv clinical | 7 |
pregnant women | 7 |
ordinal scale | 7 |
diagnostic codes | 7 |
nucleic acid | 7 |
million people | 7 |
early detection | 7 |
new coronavirus | 7 |
acute myocardial | 7 |
level evidence | 7 |
executive order | 7 |
ed length | 7 |
standard care | 7 |
severe symptoms | 7 |
medical services | 7 |
healthcare professionals | 7 |
interim guidance | 7 |
protein binding | 7 |
different types | 7 |
within days | 7 |
several studies | 7 |
advanced airway | 7 |
disease burden | 7 |
critical disease | 7 |
close contact | 7 |
hypertonic saline | 7 |
respiratory infections | 7 |
three days | 7 |
mortality rate | 7 |
nasopharyngeal swab | 7 |
ed volume | 7 |
vasopressor support | 7 |
continuous chest | 7 |
experimental group | 7 |
china clinical | 7 |
angiotensin ii | 7 |
patients received | 7 |
renal impairment | 7 |
acute heart | 7 |
one day | 7 |
invasive mechanical | 7 |
severe pneumonia | 7 |
commonly reported | 7 |
day mortality | 7 |
american journal | 7 |
three cases | 7 |
respirator fit | 7 |
severe toxicity | 7 |
symptomatic patients | 7 |
generating procedures | 7 |
current pandemic | 7 |
posttraumatic growth | 7 |
european resuscitation | 7 |
confidence interval | 7 |
hour return | 7 |
positive airway | 7 |
adult patients | 7 |
flow rate | 7 |
conventional oxygen | 7 |
endothelial cells | 7 |
may occur | 7 |
nonrandomized studies | 7 |
surgical mask | 7 |
cardiovascular care | 7 |
segment elevation | 7 |
sodium acetate | 7 |
mass index | 7 |
scoping review | 7 |
surviving sepsis | 7 |
time period | 7 |
health emergency | 7 |
body weight | 7 |
gold standard | 6 |
severe group | 6 |
valve mask | 6 |
atypical presentations | 6 |
study reported | 6 |
inflammatory markers | 6 |
hfnc group | 6 |
higher risk | 6 |
sodium bicarbonate | 6 |
patients returning | 6 |
orbital compartment | 6 |
organ systems | 6 |
clinical studies | 6 |
higher rate | 6 |
rapid onset | 6 |
report annual | 6 |
viral load | 6 |
vision loss | 6 |
rheumatoid arthritis | 6 |
following acute | 6 |
transcription polymerase | 6 |
acute aminoquinoline | 6 |
study conducted | 6 |
sepsis campaign | 6 |
ingested dose | 6 |
chloroquine phosphate | 6 |
care medicine | 6 |
rescue analgesia | 6 |
inclusion criteria | 6 |
blood chloroquine | 6 |
serum abnormalities | 6 |
racemic epinephrine | 6 |
ct results | 6 |
meq kg | 6 |
ed setting | 6 |
control measures | 6 |
one patient | 6 |
elevation myocardial | 6 |
association analysis | 6 |
flow test | 6 |
standard deviation | 6 |
intravenous magnesium | 6 |
protective effect | 6 |
chloroquine toxicity | 6 |
among covid | 6 |
occupational safety | 6 |
increasing number | 6 |
emergency room | 6 |
high flow | 6 |
spared areas | 6 |
croup patients | 6 |
health commission | 6 |
nitrous oxide | 6 |
clinical management | 6 |
traditional chinese | 6 |
prospective cohort | 6 |
early diagnosis | 6 |
supplemental oxygen | 6 |
narrative review | 6 |
mechanically ventilated | 6 |
clinical severity | 6 |
class ia | 6 |
median time | 6 |
nitric oxide | 6 |
acute intoxication | 6 |
clinically significant | 6 |
two studies | 6 |
ill covid | 6 |
hospital blinded | 6 |
suspected ingested | 6 |
magnesium group | 6 |
obstructive pulmonary | 6 |
appropriate ppe | 6 |
table shows | 6 |
prochlorperazine group | 6 |
may increase | 6 |
following ingestion | 6 |
tidal volume | 6 |
data analysis | 6 |
respiratory illness | 6 |
adequate protection | 6 |
airborne precautions | 6 |
gi symptoms | 6 |
tertiary care | 6 |
among healthcare | 6 |
national institute | 6 |
systematic reviews | 6 |
placebo group | 6 |
ebola virus | 6 |
significantly associated | 6 |
compartment syndrome | 6 |
percent increase | 6 |
pressure ventilation | 6 |
descriptive statistics | 6 |
neuroleptic malignant | 6 |
effects model | 6 |
ventricular fibrillation | 6 |
higher mortality | 6 |
diabetic ketoacidosis | 6 |
lung zones | 6 |
malignant syndrome | 6 |
disease progression | 6 |
ed patient | 6 |
health departments | 6 |
qrs complex | 6 |
nervous system | 6 |
may improve | 6 |
thromboembolic complications | 6 |
special consideration | 6 |
chronic obstructive | 6 |
positive pressure | 6 |
bundle branch | 6 |
twice daily | 5 |
lipid emulsion | 5 |
health insurance | 5 |
among black | 5 |
may reduce | 5 |
global burden | 5 |
outcomes among | 5 |
lung disease | 5 |
practice guidelines | 5 |
decreased ed | 5 |
among hcws | 5 |
high volume | 5 |
another study | 5 |
south korea | 5 |
critical illness | 5 |
airborne diseases | 5 |
may worsen | 5 |
left ventricular | 5 |
significant decrease | 5 |
hubei province | 5 |
clinical symptoms | 5 |
cpr quality | 5 |
patients without | 5 |
triple medication | 5 |
time periods | 5 |
psychiatric emergency | 5 |
acute cardiac | 5 |
barre syndrome | 5 |
available evidence | 5 |
icu admission | 5 |
multiple organ | 5 |
admitted within | 5 |
basic life | 5 |
mortality rates | 5 |
failure due | 5 |
statistical analysis | 5 |
ed discharge | 5 |
severe coronavirus | 5 |
niv group | 5 |
care systems | 5 |
return visits | 5 |
respiratory diseases | 5 |
health recommendations | 5 |
waterfall sign | 5 |
sars transmission | 5 |
may help | 5 |
risk covid | 5 |
coronavirus pandemic | 5 |
bilateral lung | 5 |
direct laryngoscopy | 5 |
hfnc niv | 5 |
viral transmission | 5 |
cohort studies | 5 |
lymphocyte ratio | 5 |
operational metrics | 5 |
family members | 5 |
initial ed | 5 |
ethnic minorities | 5 |
available data | 5 |
lockdown period | 5 |
healthcare systems | 5 |
pediatric physicians | 5 |
referral hospital | 5 |
per year | 5 |
returning within | 5 |
american college | 5 |
seven rcts | 5 |
one week | 5 |
air flow | 5 |
extracorporeal membrane | 5 |
ml kg | 5 |
clinical efficacy | 5 |
intravenous lipid | 5 |
rapidly evolving | 5 |
worsening hypoxemia | 5 |
medical therapy | 5 |
positive patients | 5 |
parotid gland | 5 |
continuous infusion | 5 |
respiratory status | 5 |
unit admission | 5 |
associated pneumonia | 5 |
readily available | 5 |
prone cpr | 5 |
severe chloroquine | 5 |
person transmission | 5 |
san francisco | 5 |
arterial pressure | 5 |
clinical presentation | 5 |
membrane oxygenation | 5 |
iv magnesium | 5 |
disease pneumonia | 5 |
supportive care | 5 |
higher compared | 5 |
integrated public | 5 |
pediatric croup | 5 |
kidney disease | 5 |
johns hopkins | 5 |
may result | 5 |
epidemiological characteristics | 5 |
practical recommendations | 5 |
lombardy region | 5 |
exact test | 5 |
lung involvement | 5 |
adrenergic receptor | 5 |
retrospective case | 5 |
multicenter study | 5 |
respiratory droplets | 5 |
respiratory acidosis | 5 |
ill adults | 5 |
considered statistically | 5 |
adel title | 5 |
activated charcoal | 5 |
cranial nerve | 5 |
association guidelines | 5 |
ed return | 5 |
oral dexamethasone | 5 |
chinese herbal | 5 |
reproductive number | 5 |
niv may | 5 |
survival group | 5 |
sars patients | 5 |
ejection fraction | 5 |
million cases | 5 |
measured using | 5 |
somatoform disorders | 5 |
written informed | 5 |
rate among | 5 |
pharmacologic therapies | 5 |
blood glucose | 5 |
noninvasive positive | 5 |
estimated probability | 5 |
thrombotic complications | 5 |
mean value | 5 |
referent hospital | 5 |
cardiovascular complications | 5 |
systolic blood | 5 |
viral particles | 5 |
versus non | 5 |
corona virus | 5 |
coronavirus outbreak | 5 |
upper respiratory | 5 |
clinical outcomes | 5 |
ed care | 5 |
clinical suspicion | 5 |
vulnerable populations | 5 |
serum concentration | 5 |
older age | 5 |
compression intubation | 5 |
retrospective analysis | 5 |
lactate dehydrogenase | 5 |
odds ratio | 5 |
medical resources | 5 |
small sample | 5 |
western medicine | 5 |
life threatening | 5 |
acute care | 5 |
branch block | 5 |
multivariable logistic | 5 |
emergency clinicians | 5 |
hours later | 4 |
cumulative doses | 4 |
th annual | 4 |
patients suffering | 4 |
air dispersion | 4 |
like illness | 4 |
specific grant | 4 |
use authorization | 4 |
lysosomal dysfunction | 4 |
provide adequate | 4 |
liver disease | 4 |
confirmed sars | 4 |
report literature | 4 |
complement activation | 4 |
serious adverse | 4 |
conversion rate | 4 |
cardiac toxicity | 4 |
transmission dynamics | 4 |
offending agent | 4 |
coronavirus transmission | 4 |
quantitative fit | 4 |
two patients | 4 |
airborne disease | 4 |
simulated workplace | 4 |
nri event | 4 |
acute onset | 4 |
elderly patients | 4 |
effects due | 4 |
rebreather mask | 4 |
hypercoagulable state | 4 |
hcq plus | 4 |
preliminary data | 4 |
ct showed | 4 |
urban academic | 4 |
overall ed | 4 |
meteorological administration | 4 |
heat stroke | 4 |
northern california | 4 |
seek care | 4 |
lethal dose | 4 |
nri non | 4 |
decontamination strategies | 4 |
highly contagious | 4 |
important lessons | 4 |
inhalant abuse | 4 |
significant increase | 4 |
triage data | 4 |
including direct | 4 |
secondary outcome | 4 |
blood count | 4 |
initial triage | 4 |
nyha iv | 4 |
laboratory confirmed | 4 |
household care | 4 |
potassium channel | 4 |
model adjusted | 4 |
inspired oxygen | 4 |
heterogeneity test | 4 |
irritant effects | 4 |
gbs secondary | 4 |
prospective study | 4 |
primary care | 4 |
aged years | 4 |
fitting powered | 4 |
decreased mortality | 4 |
high dose | 4 |
influenza virus | 4 |
triage systems | 4 |
ambient pm | 4 |
hospital beds | 4 |
potential conflicts | 4 |
crossover study | 4 |
face seal | 4 |
pandemic era | 4 |
travel restrictions | 4 |
evaluated using | 4 |
patient data | 4 |
laerdal medical | 4 |
creatine kinase | 4 |
cases compared | 4 |
immune system | 4 |
findings may | 4 |
prior years | 4 |
significant associations | 4 |
medication regimen | 4 |
standard cpr | 4 |
ems arrival | 4 |
nerve involvement | 4 |
presenting symptoms | 4 |
laboratory tests | 4 |
ile use | 4 |
air purifying | 4 |
video laryngoscope | 4 |
control cohort | 4 |
varying baseline | 4 |
square test | 4 |
healthcare settings | 4 |
chloroquine concentrations | 4 |
older eps | 4 |
mild hypercapnia | 4 |
odds ratios | 4 |
city area | 4 |
normal qrs | 4 |
rare complication | 4 |
passed group | 4 |
confirmed case | 4 |
several limitations | 4 |
selection bias | 4 |
significantly different | 4 |
emergency management | 4 |
pleural effusion | 4 |
chest computed | 4 |
mental disorders | 4 |
preepidemic period | 4 |
continuous data | 4 |
beneficial effects | 4 |
additional qt | 4 |
chest radiograph | 4 |
medical records | 4 |
viral pneumonia | 4 |
lupus erythematosus | 4 |
clinical infectious | 4 |
fatal patients | 4 |
excreted renally | 4 |
electronic medical | 4 |
rapid sequence | 4 |
coronavirus diseases | 4 |
negative predictive | 4 |
profit sectors | 4 |
toxic dose | 4 |
icu group | 4 |
lower limbs | 4 |
hospital capacity | 4 |
start cpr | 4 |
iv symptoms | 4 |
severe patients | 4 |
ultrasound findings | 4 |
many patients | 4 |
remdesivir group | 4 |
several factors | 4 |
review manager | 4 |
peak incidence | 4 |
potassium levels | 4 |
committee decision | 4 |
covid infection | 4 |
positive end | 4 |
reverse transcription | 4 |
significantly increased | 4 |
home order | 4 |
demographic characteristics | 4 |
one case | 4 |
pharmacological treatment | 4 |
retinal toxicity | 4 |
beats per | 4 |
patients older | 4 |
channel blockade | 4 |
coronary heart | 4 |
barky cough | 4 |
personal protection | 4 |
exclusion criteria | 4 |
york times | 4 |
significant heterogeneity | 4 |
kg body | 4 |
conventional therapy | 4 |
acute overdose | 4 |
pulmonary inflammation | 4 |
serotonin syndrome | 4 |
nosocomial infection | 4 |
viral entry | 4 |
level ordinal | 4 |
toxicity occurs | 4 |
serologic testing | 4 |
two rcts | 4 |
pandemic covid | 4 |
mission district | 4 |
case subjects | 4 |
year old | 4 |
global pandemic | 4 |
delayed intubation | 4 |
western india | 4 |
two weeks | 4 |
altered mentation | 4 |
test positive | 4 |
another case | 4 |
relative humidity | 4 |
particulate matter | 4 |
day group | 4 |
syndrome associated | 4 |
viral pathogens | 4 |
chinese center | 4 |
facepiece respirator | 4 |
patients must | 4 |
may develop | 4 |
ground glass | 4 |
airway operator | 4 |
metoclopramide group | 4 |
cov infection | 4 |
april th | 4 |
categorical variables | 4 |
significantly longer | 4 |
media briefing | 4 |
vulnerable patients | 4 |
endothelial cell | 4 |
levels may | 4 |
clinical presentations | 4 |
mean pm | 4 |
viral nucleic | 4 |
anesthesiology teams | 4 |
effects associated | 4 |
septic shock | 4 |
viral infections | 4 |
cardiac massage | 4 |
two cases | 4 |
venous air | 4 |
early identification | 4 |
staff exposure | 4 |
postepidemic period | 4 |
control groups | 4 |
day one | 4 |
arterial blood | 4 |
health outcomes | 4 |
hemodynamic parameters | 4 |
clavicular line | 4 |
pcr test | 4 |
years old | 4 |
service industry | 4 |
mechanical failures | 4 |
heart rates | 4 |
severe course | 4 |
sodium channel | 4 |
decision making | 4 |
face shield | 4 |
receptor binding | 4 |
march nd | 4 |
treating covid | 4 |
ncov pneumonia | 4 |
clinical setting | 4 |
teams caring | 4 |
aminoquinoline intoxication | 4 |
staff safety | 4 |
ill icu | 4 |
flow oxygen | 4 |
improve oxygenation | 4 |
presenting characteristics | 4 |
cardiovascular disease | 4 |
glass opacities | 4 |
relative risks | 4 |
breaths per | 4 |
following sections | 4 |
financial support | 4 |
prone positioned | 4 |
early stages | 4 |
weakness fall | 4 |
three time | 4 |
chronic health | 4 |
expiratory pressure | 4 |
viral rna | 4 |
pain score | 4 |
tract infection | 4 |
tube disconnection | 4 |
two hospitals | 4 |
ahs ed | 4 |
immune function | 4 |
warranting special | 4 |
guidelines update | 4 |
relatively low | 4 |
orogastric lavage | 4 |
patient outcomes | 4 |
failed niv | 4 |
control center | 4 |
systemic review | 4 |
normal systolic | 4 |
massive pulmonary | 4 |
governor cuomo | 4 |
video laryngoscopy | 4 |
pcr assay | 4 |
ct imaging | 4 |
structural heart | 4 |
often seen | 4 |
independent risk | 4 |
old female | 4 |
thromboembolic disease | 4 |
closely monitored | 4 |
regression analysis | 4 |
eye protection | 4 |
human transmission | 4 |
ethics committee | 4 |
may th | 4 |
visual acuity | 4 |
oxidative stress | 4 |
physical distancing | 4 |
san diego | 4 |
significant association | 4 |
atrial fibrillation | 4 |
thromboembolic events | 4 |
care alone | 4 |
patient presented | 4 |
study include | 4 |
ed encounter | 4 |
intubation using | 4 |
study clinical | 4 |
air pressure | 4 |
five patients | 4 |
studies involving | 4 |
team member | 4 |
three eds | 4 |
washington state | 4 |
limited resources | 4 |
right heart | 4 |
angiotensin converting | 4 |
complete blood | 4 |
lus findings | 4 |
ia antiarrhythmics | 4 |
hospital stay | 4 |
electrolyte derangements | 4 |
ems system | 4 |
severe illness | 4 |
conventional treatment | 4 |
sars outbreak | 4 |
mean temperature | 4 |
funding agencies | 4 |
predict intubation | 4 |
ed visit | 4 |
older patients | 4 |
initial covid | 3 |
searched pubmed | 3 |
induced lung | 3 |
language barriers | 3 |
first documented | 3 |
provided feedback | 3 |
annual ed | 3 |
imaging features | 3 |
interquartile range | 3 |
also increase | 3 |
mg every | 3 |
initial results | 3 |
median ed | 3 |
large thrombus | 3 |
chart review | 3 |
coronavirus resource | 3 |
task force | 3 |
even death | 3 |
internal medicine | 3 |
health administration | 3 |
correct use | 3 |
publication bias | 3 |
icd codes | 3 |
pressure room | 3 |
information system | 3 |
frontline healthcare | 3 |
vocal cords | 3 |
old age | 3 |
analysis based | 3 |
essential services | 3 |
experienced difficulty | 3 |
third nre | 3 |
skeletal muscle | 3 |
initial presentation | 3 |
compression depth | 3 |
lower respiratory | 3 |
patients presented | 3 |
patients experienced | 3 |
oxygen supplementation | 3 |
use papr | 3 |
disease outbreak | 3 |
two investigators | 3 |
doubling time | 3 |
hopkins coronavirus | 3 |
general population | 3 |
relatively lower | 3 |
respiratory illnesses | 3 |
blower flow | 3 |
group compared | 3 |
pairwise comparison | 3 |
financial interest | 3 |
old previously | 3 |
emergency airway | 3 |
latinx communities | 3 |
intoxicated patients | 3 |
seek medical | 3 |
fatal air | 3 |
disposable gown | 3 |
psychiatric emergencies | 3 |
safety net | 3 |
intravenous fluids | 3 |
mean arterial | 3 |
april st | 3 |
baseline pao | 3 |
hospital campuses | 3 |
protective effects | 3 |
wuhan city | 3 |
systematic analysis | 3 |
among emergency | 3 |
additional medications | 3 |
airborne transmission | 3 |
highest level | 3 |
myocardial injury | 3 |
epithelial cells | 3 |
unique group | 3 |
systemic lupus | 3 |
korea centers | 3 |
northeast chongqing | 3 |
health team | 3 |
coronavirus infections | 3 |
also performed | 3 |
supine cpr | 3 |
national emergency | 3 |
intubation methods | 3 |
close monitoring | 3 |
daily ed | 3 |
many guidelines | 3 |
may pose | 3 |
hospital day | 3 |
fluid resuscitation | 3 |
pandemic will | 3 |
pneumonia infected | 3 |
hospital avoiding | 3 |
disease study | 3 |
participants passed | 3 |
median daily | 3 |
boarding time | 3 |
global health | 3 |
cell entry | 3 |
hypoxemia despite | 3 |
pain center | 3 |
ggo lesions | 3 |
medical contact | 3 |
intubated patients | 3 |
th may | 3 |
pro respirator | 3 |
infanta leonor | 3 |
universitario infanta | 3 |
associated ahrf | 3 |
cerebral mucormycosis | 3 |
quarantine implications | 3 |
acute st | 3 |
pathological findings | 3 |
critical condition | 3 |
tertiary hospital | 3 |
injection molding | 3 |
included study | 3 |
study evaluating | 3 |
shown apparent | 3 |
treatment arms | 3 |
emergency diseases | 3 |
large variance | 3 |
may affect | 3 |
ambient aerosol | 3 |
suggested cdc | 3 |
tract infections | 3 |
disposition decision | 3 |
efficiency particulate | 3 |
dry cough | 3 |
median pain | 3 |
participants failed | 3 |
better isolate | 3 |
several reasons | 3 |
viral shedding | 3 |
week prior | 3 |
loose stools | 3 |
underwent nasopharyngeal | 3 |
control centers | 3 |
cannula therapy | 3 |
emergency paramedics | 3 |
expert recommendations | 3 |
center study | 3 |
patients accounted | 3 |
studies among | 3 |
got nosocomial | 3 |
ventilation failure | 3 |
substance use | 3 |
utmost importance | 3 |
patients coming | 3 |
studies included | 3 |
tour hospital | 3 |
health record | 3 |
testing sites | 3 |
higher rates | 3 |
similar pattern | 3 |
wilcoxon rank | 3 |
phosphate dehydrogenase | 3 |
spontaneously hypertensive | 3 |
study date | 3 |
respondents reported | 3 |
study aimed | 3 |
hypertensive rats | 3 |
pneumonia clinical | 3 |
remdesivir therapy | 3 |
organ dysfunction | 3 |
junyi zheng | 3 |
hydroxychloroquine use | 3 |
particulate air | 3 |
affiliated hospital | 3 |
often presents | 3 |
typically present | 3 |
risk patients | 3 |
test results | 3 |
infection presented | 3 |
plasma therapy | 3 |
doc time | 3 |
intubation period | 3 |
farmer worker | 3 |
mean improvement | 3 |
dear editor | 3 |
general public | 3 |
weather factors | 3 |
psychiatric disease | 3 |
covid pandemic | 3 |
america clinical | 3 |
among health | 3 |
positive predictive | 3 |
stata version | 3 |
required oxygen | 3 |
therapeutic range | 3 |
risk procedure | 3 |
persistent stridor | 3 |
urgent need | 3 |
glycemic control | 3 |
missing data | 3 |
data source | 3 |
care lung | 3 |
urgent care | 3 |
cardiac involvement | 3 |
pco mmhg | 3 |
regression model | 3 |
york state | 3 |
kidney function | 3 |
gender disparities | 3 |
respiratory virus | 3 |
alameda county | 3 |
often present | 3 |
collected data | 3 |
highly infectious | 3 |
eps age | 3 |
asymptomatic patients | 3 |
ed pharmacist | 3 |
cdc study | 3 |
study covid | 3 |
diseases society | 3 |
renal disease | 3 |
zoonotic origin | 3 |
label design | 3 |
low risk | 3 |
mm hg | 3 |
breaths minute | 3 |
minimize aerosolization | 3 |
china genomic | 3 |
center simulation | 3 |
results suggest | 3 |
one hand | 3 |
group received | 3 |
patients per | 3 |
resource center | 3 |
magnetic resonance | 3 |
user experience | 3 |
effect model | 3 |
ppe may | 3 |
china medical | 3 |
magnesium sulphate | 3 |
viral infection | 3 |
took part | 3 |
avoiding behavior | 3 |
pandemic date | 3 |
hospital emergency | 3 |
partial pressure | 3 |
substantial proportion | 3 |
among latinx | 3 |
cardiovascular diseases | 3 |
air pollutant | 3 |
review article | 3 |
require intubation | 3 |
report describes | 3 |
care professionals | 3 |
newly diagnosed | 3 |
psychiatric patients | 3 |
exposure prophylaxis | 3 |
cutanea tarda | 3 |
cow urine | 3 |
performing cpr | 3 |
adjusted relative | 3 |
positive rt | 3 |
laboratory values | 3 |
reported adverse | 3 |
advanced life | 3 |
sum test | 3 |
isolate covid | 3 |
carbon dioxide | 3 |
right ventricular | 3 |
porphyria cutanea | 3 |
developed respiratory | 3 |
single center | 3 |
pathogen transmission | 3 |
receptor antagonist | 3 |
airway intervention | 3 |
residency program | 3 |
cpr guidelines | 3 |
affected geographic | 3 |
based treatment | 3 |
closed system | 3 |
serious medical | 3 |
patients reported | 3 |
resuscitative measures | 3 |
surgical field | 3 |
anticoagulant treatment | 3 |
triage tool | 3 |
patients treated | 3 |
patients used | 3 |
hospital death | 3 |
axillary line | 3 |
common symptoms | 3 |
poor prognosis | 3 |
term exposure | 3 |
commonly associated | 3 |
extra protection | 3 |
daily number | 3 |
cardiovascular effects | 3 |
ras axis | 3 |
paramedics negotiated | 3 |
medical co | 3 |
particularly vulnerable | 3 |
pleural consolidations | 3 |
plus azithromycin | 3 |
official publication | 3 |
pressure ward | 3 |
seven days | 3 |
neurologic manifestations | 3 |
diagnosed diabetes | 3 |
current covid | 3 |
refractory hypoxemia | 3 |
develop acute | 3 |
health crisis | 3 |
training session | 3 |
secondary outcomes | 3 |
care services | 3 |
patient developed | 3 |
administered mg | 3 |
invasive respiratory | 3 |
physical exam | 3 |
appendix table | 3 |
roadside stations | 3 |
great impact | 3 |
care system | 3 |
healthy volunteers | 3 |
may need | 3 |
ed clinicians | 3 |
nosocomial transmission | 3 |
venous blood | 3 |
virus origins | 3 |
council guidelines | 3 |
cardiac electrical | 3 |
health authorities | 3 |
infected people | 3 |
china coronavirus | 3 |
fit tester | 3 |
aerosol generating | 3 |
net reclassification | 3 |
significant effect | 3 |
clinical effective | 3 |
hours spent | 3 |
ace expression | 3 |
affiliated hospitals | 3 |
statistical significance | 3 |
pneumonia outbreak | 3 |
advanced age | 3 |
department using | 3 |
psychiatric ed | 3 |
chloroquine ingestion | 3 |
immediate post | 3 |
management strategies | 3 |
high quality | 3 |
virus pandemic | 3 |
study using | 3 |
medical record | 3 |
slightly higher | 3 |
aha guidelines | 3 |
based tests | 3 |
multiple reports | 3 |
college station | 3 |
ed physician | 3 |
outdoor non | 3 |
lower lung | 3 |
literature review | 3 |
mean concentrations | 3 |
admission criteria | 3 |
respiratory disease | 3 |
fit testing | 3 |
two cohort | 3 |
female presented | 3 |
participants performed | 3 |
study found | 3 |
time reverse | 3 |
tsi inc | 3 |
electronic health | 3 |
compared using | 3 |
mean concentration | 3 |
pcr panel | 3 |
old woman | 3 |
potassium repletion | 3 |
influenza infection | 3 |
intravenous remdesivir | 3 |
include fever | 3 |
assess whether | 3 |
special attention | 3 |
health conditions | 3 |
endothelial dysfunction | 3 |
three hours | 3 |
study performed | 3 |
print repositories | 3 |
single health | 3 |
physiologic changes | 3 |
herbal formulas | 3 |
hcq group | 3 |
massive pe | 3 |
pharmacologic agents | 3 |
hospital universitario | 3 |
patient presentation | 3 |
prolonged qt | 3 |
patients present | 3 |
false negative | 3 |
ed los | 3 |
inspiratory stridor | 3 |
receptor recognition | 3 |
examination showed | 3 |
oxygen airflow | 3 |
treat patients | 3 |
categorical data | 3 |
ambulance bay | 3 |
illness among | 3 |
significant morbidity | 3 |
requiring intubation | 3 |
physical examination | 3 |
positivity rates | 3 |
mg twice | 3 |
sputum production | 3 |
unscheduled return | 3 |
serum levels | 3 |
health department | 3 |
virus responsible | 3 |
nested control | 3 |
prolonging medications | 3 |
baseline clinical | 3 |
additional clinical | 3 |
among hospitalized | 3 |
protecting health | 3 |
magnesium compared | 3 |
included patients | 3 |
important role | 3 |
also confirmed | 3 |
two university | 3 |
ed performance | 3 |
seattle region | 3 |
minute ventilation | 3 |
febrile patients | 3 |
medicaid services | 3 |
critical patients | 3 |
treatment options | 3 |
ems call | 3 |
purifying respirator | 3 |
escalation therapy | 3 |
new onset | 3 |
employment status | 3 |
upper limbs | 3 |
proper personal | 3 |
new cases | 3 |
treat covid | 3 |
disease key | 3 |
hyperbaric oxygen | 3 |
guidelines recommend | 3 |
carefully monitored | 3 |
blood concentrations | 3 |
data set | 3 |
growing number | 3 |
supply chain | 3 |
initial visit | 3 |
related impacts | 3 |
factors including | 3 |
international concern | 3 |
normally distributed | 3 |
march st | 3 |
heat illness | 3 |
spike protein | 3 |
apparent efficacy | 3 |
two hours | 3 |
diagnosing covid | 3 |
aldosterone system | 3 |
personal responsibilities | 3 |
min operation | 3 |
risk assessment | 3 |
chronic medical | 3 |
targeted distribution | 3 |
early transmission | 3 |
dexmedetomidine may | 3 |
ensure adequate | 3 |
guidance exists | 3 |
related coronavirus | 3 |
demographic data | 3 |
endothelial function | 3 |
study comparing | 3 |
single patient | 3 |
aggressive resuscitative | 3 |
many countries | 3 |
qt intervals | 3 |
respiratory pathophysiology | 3 |
ct based | 3 |
rheumatologic diseases | 3 |
poor outcomes | 3 |
renal insufficiency | 3 |
hospital resources | 3 |
preliminary report | 3 |
cm compression | 3 |
attending physicians | 3 |
grade power | 3 |
acid negative | 3 |
arrest occurring | 3 |
developed countries | 3 |
behavior among | 3 |
control recommendations | 3 |
quality cpr | 3 |
detectable viral | 3 |
medical procedures | 3 |
patients aged | 3 |
acute management | 3 |
associated parotitis | 3 |
pg ml | 3 |
help triage | 3 |
medical worker | 3 |
another rct | 3 |
limitations include | 3 |
medical decision | 3 |
improperly sized | 3 |
following criteria | 3 |
tidal volumes | 3 |
full text | 3 |
diagnostic tests | 3 |
adult patient | 3 |
within one | 3 |
ed within | 3 |
particular mass | 3 |
novel high | 3 |
acute migraine | 3 |
community transmission | 3 |
study showed | 3 |
described covid | 3 |
home orders | 3 |
critical cases | 3 |
like symptoms | 3 |
also compared | 3 |
hurricane sandy | 3 |
versus severe | 3 |
medicine xxx | 3 |
liver injury | 3 |
severe versus | 3 |
cdc guidelines | 3 |
clinical manifestations | 3 |
complaint data | 3 |
several reports | 3 |
close attention | 3 |
study drugs | 3 |
effective rate | 3 |
chronic heart | 3 |
treatment time | 3 |
home isolation | 3 |
animal models | 3 |
infected individuals | 3 |
independently associated | 3 |
inflammatory response | 3 |
early intubation | 3 |
may require | 3 |
disease patients | 3 |
nebulized racemic | 3 |
interquartile ranges | 3 |
past days | 3 |
fitting hood | 3 |
shufeng jiedu | 3 |
monitoring stations | 3 |
hospitalization rates | 3 |
study participants | 3 |
isolation room | 3 |
pulmonary circulation | 3 |
public transport | 3 |
health effects | 3 |
meier survival | 3 |
antithrombotic effect | 3 |
requiring oxygen | 3 |
daily hospital | 3 |
ct features | 3 |
atypical complaints | 3 |
genomic characterisation | 3 |
mg daily | 3 |
transmission among | 3 |
staff got | 3 |
standard precautions | 3 |
salivary gland | 3 |
medicine clinical | 3 |
thrombus formation | 3 |
mortality due | 3 |
performed continuous | 3 |
pes volume | 3 |
wuhan clinical | 3 |
age ranging | 3 |
analysis date | 3 |
early stage | 3 |
inflammatory processes | 3 |
findings highlight | 3 |
three rcts | 3 |
oronasal masks | 3 |
severe complications | 3 |
operation time | 3 |
exogenous oxygen | 3 |
included studies | 3 |
days later | 3 |
muscular dystrophy | 3 |
vessel stroke | 3 |
never experienced | 3 |
wuhan university | 3 |
treatment room | 3 |
severe respiratory | 3 |
triage patients | 3 |
favor due | 3 |
first medical | 3 |
high efficiency | 3 |
day course | 3 |
cardiovascular emergencies | 3 |
documented cases | 3 |
severe croup | 3 |
initial dexamethasone | 3 |
surgical masks | 3 |
also found | 3 |
conventional qnft | 3 |
viral illnesses | 3 |
five days | 3 |
spinal surgery | 3 |
generating procedure | 3 |
aminoquinoline use | 3 |
widely used | 3 |
oxygen support | 3 |
korean meteorological | 3 |
protection equipment | 3 |
great need | 3 |
mortality outcomes | 3 |
human services | 3 |
dexmedetomidine infusion | 3 |
physicians date | 3 |
oxygen devices | 3 |
modelling study | 3 |
vectored covid | 3 |
line abnormalities | 3 |
cardiac output | 3 |
showed significant | 3 |
symptom scores | 3 |
ventricular ejection | 3 |
differential diagnosis | 3 |
care units | 3 |
difficult airway | 3 |
herbal medicine | 3 |
second one | 3 |
patients diagnosed | 3 |
oxygen escalation | 3 |
us population | 3 |
coronaviridae family | 3 |
appropriate equipment | 3 |
adults hospitalized | 3 |
low dose | 3 |
severe critical | 3 |
open label | 3 |
whole blood | 3 |
using vie | 2 |
significant venous | 2 |
days prior | 2 |
fall ams | 2 |
untreated ahf | 2 |
conduction blocks | 2 |
insulin secretion | 2 |
left without | 2 |
academic center | 2 |
last two | 2 |
previous one | 2 |
fair allocation | 2 |
practices may | 2 |
analyzed data | 2 |
lopinavir mg | 2 |
photoreceptors damage | 2 |
acute poisoning | 2 |
describe effects | 2 |
lung ultrasonography | 2 |
detailing ecmo | 2 |
ocular symptoms | 2 |
gam models | 2 |
often follows | 2 |
discovering patients | 2 |
cases transaminases | 2 |
adults aged | 2 |
collected using | 2 |
workers helping | 2 |
brain natriuretic | 2 |
toxicity manifests | 2 |
cautiously used | 2 |
workplace activities | 2 |
technically difficult | 2 |
reduced glutathione | 2 |
arm leg | 2 |
care society | 2 |
chronic renal | 2 |
review risk | 2 |
patient encounters | 2 |
yy abob | 2 |
previously suggested | 2 |
including jaundice | 2 |
ff decreased | 2 |
currently exist | 2 |
morbidity conditions | 2 |
respiratory insufficiency | 2 |
clinically proven | 2 |
deep vein | 2 |
promoting better | 2 |
another benzodiazepine | 2 |
viral testing | 2 |
ecmo use | 2 |
pressure rooms | 2 |
direct gastric | 2 |
walk test | 2 |
abstract form | 2 |
neurotransmitter concentrations | 2 |
ethical standards | 2 |
spread rapidly | 2 |
mucosal thickening | 2 |
recent trials | 2 |
potassium may | 2 |
worldwide public | 2 |
st day | 2 |
suggests hemodialysis | 2 |
failure ards | 2 |
vessel vasculitis | 2 |
clinical indications | 2 |
six wzxz | 2 |
moderate retractions | 2 |
th day | 2 |
large volume | 2 |
erroneously perceived | 2 |
potential antiviral | 2 |
disease mortality | 2 |
initial blood | 2 |
human immunodeficiency | 2 |
appropriate viral | 2 |
type ii | 2 |
sodium load | 2 |
days back | 2 |
toxicity depend | 2 |
adequately raise | 2 |
significant risk | 2 |
situ simulation | 2 |
safer options | 2 |
many personnel | 2 |
produce toxicity | 2 |
flow diagram | 2 |
class i | 2 |
delays repolarization | 2 |
producing characteristic | 2 |
anion gap | 2 |
hand hygiene | 2 |
aerosol generation | 2 |
related encounters | 2 |
immunocompromised state | 2 |
media coverage | 2 |
partial arterial | 2 |
subclinical coronavirus | 2 |
travel along | 2 |
survival rate | 2 |
daily maximal | 2 |
authors declared | 2 |
heightened risk | 2 |
work performance | 2 |
significantly shorter | 2 |
aminoquinoline doses | 2 |
ingested quantity | 2 |
term ile | 2 |
optimal treatment | 2 |
shorter median | 2 |
low sensitivity | 2 |
multisystem inflammatory | 2 |
data since | 2 |
prolongation associated | 2 |
cases versus | 2 |
weekly rates | 2 |
induced conduction | 2 |
mask seal | 2 |
among critically | 2 |
reference diagnoses | 2 |
positive chest | 2 |
medical use | 2 |
partially passed | 2 |
herbal medicines | 2 |
familial cluster | 2 |
treatment times | 2 |
concentration required | 2 |
towards controlling | 2 |
substantially decreased | 2 |
also present | 2 |
everyday preventative | 2 |
system inhibitors | 2 |
potential domestic | 2 |
four limbs | 2 |
zwg ueyb | 2 |
studies revealed | 2 |
induced ocular | 2 |
heterogeneity among | 2 |
reserved wards | 2 |
improving compliance | 2 |
antimalarial drugs | 2 |
underlying hypokalemia | 2 |
arterial vasodilation | 2 |
overdose demonstrates | 2 |
blood cell | 2 |
one investigator | 2 |
chronic toxicity | 2 |
radical accumulation | 2 |
venturi mask | 2 |
less time | 2 |
healthcare provider | 2 |
niv intolerance | 2 |
revealed elevated | 2 |
nasopharyngeal covid | 2 |
data available | 2 |
classic pr | 2 |
showed hyperglycemia | 2 |
group showed | 2 |
using sodium | 2 |
myocardial sodium | 2 |
saturation improvement | 2 |
avoid overcrowding | 2 |
oxygen delivery | 2 |
studies comparing | 2 |
june th | 2 |
statistically higher | 2 |
inward leakage | 2 |
restrictive features | 2 |
inhibit myocardial | 2 |
avoiding qtc | 2 |
sulfur dioxide | 2 |
still likely | 2 |
interaction inverse | 2 |
medical college | 2 |
patients seek | 2 |
performed according | 2 |
redistribution prompts | 2 |
deeper consolidation | 2 |
vision despite | 2 |
responsible authorities | 2 |
persistent endorgan | 2 |
reported increased | 2 |
care centres | 2 |
human coronaviruses | 2 |
inflammatory responses | 2 |
qt prolonging | 2 |
mortality compared | 2 |
fascicular block | 2 |
since past | 2 |
one early | 2 |
natural history | 2 |
previously reported | 2 |
serologic tests | 2 |
although initial | 2 |
remarkable recovery | 2 |
diastolic pressure | 2 |
data date | 2 |
experiencing symptoms | 2 |
gas tests | 2 |
results included | 2 |
receptor antagonism | 2 |
decrease aminoquinoline | 2 |
period revealed | 2 |
pooled incidence | 2 |
eligible studies | 2 |
without severe | 2 |
registration desks | 2 |
creatine phosphokinase | 2 |
bilateral pneumonia | 2 |
five minutes | 2 |
controlled study | 2 |
positive tests | 2 |
nasal high | 2 |
alerted mental | 2 |
national data | 2 |
early recognition | 2 |
protracted recovery | 2 |
effective means | 2 |
warrants physicians | 2 |
respiratory medicine | 2 |
symptoms may | 2 |
generalised hypotonia | 2 |
proximal muscles | 2 |
level disinfectants | 2 |
test probability | 2 |
intubation staging | 2 |
sinus mucosal | 2 |
unintended toxicity | 2 |
diffuse alveolar | 2 |
demonstrates improved | 2 |
fall altered | 2 |
visual fields | 2 |
concerns regarding | 2 |
medications metabolized | 2 |
skin irritation | 2 |
peep valve | 2 |
phospholipid accumulation | 2 |
prone cardiopulmonary | 2 |
disease outbreaks | 2 |
prolong survival | 2 |
states clinical | 2 |
analysis revealed | 2 |
yggo yk | 2 |
requiring mechanical | 2 |
occur rapidly | 2 |
continuous variable | 2 |
unless specified | 2 |
known covid | 2 |
may preclude | 2 |
exerts greater | 2 |
overall fit | 2 |
organ dysfunctions | 2 |
showed promising | 2 |
mechanical complications | 2 |
irreversible loss | 2 |
help decrease | 2 |
metabolic derangements | 2 |
contributed substantially | 2 |
cardiac tamponade | 2 |
recommendations regarding | 2 |
doses exceeding | 2 |
disease entities | 2 |
end tidal | 2 |
category showed | 2 |
novel case | 2 |
laerdal pc | 2 |
meteorological data | 2 |
eventually directed | 2 |
epidemiologic concern | 2 |
related worries | 2 |
new zealand | 2 |
recent case | 2 |
near future | 2 |
statistical office | 2 |
structured triage | 2 |
following admission | 2 |
respirator failure | 2 |
dependent ability | 2 |
degenerative changes | 2 |
herbs combined | 2 |
entrance directing | 2 |
right bundle | 2 |
initial emergency | 2 |
abnormal coagulation | 2 |
unnecessary exposure | 2 |
offers several | 2 |
melanin cells | 2 |
psychiatric substance | 2 |
following variables | 2 |
observed toxicity | 2 |
underlying aminoquinoline | 2 |
aminoquinoline overdose | 2 |
specific elisa | 2 |
em physician | 2 |
otolaryngol head | 2 |
mean ejection | 2 |
ophthalmic sequelae | 2 |
ards partial | 2 |
combination group | 2 |
typical symptoms | 2 |
pandemic led | 2 |
emergency severity | 2 |
remain significant | 2 |
present study | 2 |
symptoms like | 2 |
massive hydroxychloroquine | 2 |
may lead | 2 |
underlying prolonged | 2 |
exhalation filter | 2 |
training program | 2 |
mean pain | 2 |
hf pilot | 2 |
disease clinical | 2 |
sized nonrandomized | 2 |
providing healthcare | 2 |
loosefitting papr | 2 |
female physicians | 2 |
potential exposure | 2 |
healthcare worker | 2 |
wearing ppe | 2 |
acutely lethal | 2 |
eventually requiring | 2 |
also reported | 2 |
described three | 2 |
management strategy | 2 |
regimens starting | 2 |
pharmacologic properties | 2 |
also warranting | 2 |
usually transient | 2 |
protective performances | 2 |
examination revealed | 2 |
produces additional | 2 |
safety profile | 2 |
medical teams | 2 |
minutes following | 2 |
recent study | 2 |
none key | 2 |
basic reproduction | 2 |
within eight | 2 |
minimum lethal | 2 |
yet fully | 2 |
therapeutic role | 2 |
care committee | 2 |
advice guideline | 2 |
department patients | 2 |
reduce mortality | 2 |
term outcomes | 2 |
performance evaluation | 2 |
total body | 2 |
dichotomous outcomes | 2 |
sent home | 2 |
transmission control | 2 |
aminoquinoline induced | 2 |
data collected | 2 |
ed arrival | 2 |
favor potassium | 2 |
reuptake inhibitors | 2 |
significant disparity | 2 |
slight differences | 2 |
also decrease | 2 |
postepidemic stage | 2 |
now named | 2 |
sulfate gm | 2 |
standard supportive | 2 |
advanced cardiovascular | 2 |
neck swelling | 2 |
urban eds | 2 |
testing inequality | 2 |
reduce covid | 2 |
although myotoxicity | 2 |
patient made | 2 |
improved cfr | 2 |
upper airway | 2 |
appropriate personal | 2 |
ed procedure | 2 |
identified based | 2 |
triage system | 2 |
principles emergency | 2 |
symptoms concerning | 2 |
every minute | 2 |
receptor agonists | 2 |
future studies | 2 |
skilled nursing | 2 |
urinary excretion | 2 |
every hours | 2 |
hypotension heighten | 2 |
late presentations | 2 |
treatment arm | 2 |
neuroscience institute | 2 |
lethal effects | 2 |
psychoactive substance | 2 |
equipment used | 2 |
household income | 2 |
greater risk | 2 |
samsung medical | 2 |
commonly presents | 2 |
cerebrovascular disease | 2 |
early data | 2 |
limited experience | 2 |
using ct | 2 |
waiting time | 2 |
often prescribed | 2 |
retinal pigment | 2 |
following signs | 2 |
ecg parameter | 2 |
practical considerations | 2 |
department within | 2 |
transient following | 2 |
analysis covid | 2 |
musculoskeletal diseases | 2 |
position prone | 2 |
triage nurse | 2 |
chloroquine overdoses | 2 |
outbreak originating | 2 |
disease compared | 2 |
daily pm | 2 |
personnel protection | 2 |
published data | 2 |
niv failed | 2 |
rate min | 2 |
uza gu | 2 |
transaminitis may | 2 |
misleading information | 2 |
pharmacologic treatments | 2 |
sputum induction | 2 |
carefully corrected | 2 |
nt pro | 2 |
prospective observational | 2 |
cerebrovascular events | 2 |
stools since | 2 |
electrocardiographic normalization | 2 |
worldwide pandemic | 2 |
participants experienced | 2 |
national knowledge | 2 |
scoping reviews | 2 |
also confounded | 2 |
will depend | 2 |
new insights | 2 |
moving forward | 2 |
department management | 2 |
control study | 2 |
within total | 2 |
patients died | 2 |
participants dropped | 2 |
study medication | 2 |
favorable side | 2 |
series study | 2 |
hemodialysis efficacy | 2 |
findings described | 2 |
diving mask | 2 |
vad mg | 2 |
high volumes | 2 |
mg mg | 2 |
ards cases | 2 |
continue seeing | 2 |
worsen cardiac | 2 |
two medical | 2 |
jiedu capsules | 2 |
per capita | 2 |
beds due | 2 |
occur regularly | 2 |
visits per | 2 |
also result | 2 |
rapidly absorbed | 2 |
abnormal ct | 2 |
department setting | 2 |
ray abnormalities | 2 |
almost every | 2 |
secondary endpoints | 2 |
describes ecmo | 2 |
low health | 2 |
cases per | 2 |
clinical trajectory | 2 |
report serum | 2 |
particulate filtering | 2 |
study limitations | 2 |
ed testing | 2 |
survival vs | 2 |
take time | 2 |
rapid outdoor | 2 |
testing announced | 2 |
causes neurologic | 2 |
highly associated | 2 |
positively associated | 2 |
guiding principles | 2 |
bacterial pneumonia | 2 |
increased survival | 2 |
early step | 2 |
evidenced based | 2 |
adapted diving | 2 |
testing may | 2 |
believe dexmedetomidine | 2 |
testing practices | 2 |
cell injury | 2 |
generally regarded | 2 |
increase risk | 2 |
complaints obtained | 2 |
chemical structure | 2 |
related gbs | 2 |
acute inflammatory | 2 |
respiratory hospital | 2 |
plastic drapes | 2 |
resusci anne | 2 |
ensure proper | 2 |
jjl ok | 2 |
practical measure | 2 |
report four | 2 |
occur due | 2 |
remains unclear | 2 |
label rct | 2 |
whenever possible | 2 |
pcr assays | 2 |
interventricular septum | 2 |
threatening pe | 2 |
neurologic phenomena | 2 |
data derives | 2 |
pivotal role | 2 |
analysis software | 2 |
current situation | 2 |
hangzhou chest | 2 |
overdose report | 2 |
following recommendations | 2 |
antibody responses | 2 |
successfully treat | 2 |
vital functions | 2 |
dilated pupil | 2 |
every year | 2 |
minimize covid | 2 |
plasma half | 2 |
line irregularity | 2 |
presumptive positive | 2 |
progressive weakness | 2 |
five different | 2 |
slower continuous | 2 |
improvement may | 2 |
neurologic damage | 2 |
last weeks | 2 |
require admission | 2 |
international cpr | 2 |
frequent findings | 2 |
baseline pain | 2 |
community spread | 2 |
descending order | 2 |
current case | 2 |
reclassification improvement | 2 |
different benzodiazepines | 2 |
shedding may | 2 |
severe overdoses | 2 |
fatality estimates | 2 |
serum potassium | 2 |
hemodynamic status | 2 |
first hours | 2 |
study demonstrates | 2 |
many aspects | 2 |
finally included | 2 |
radiograph showed | 2 |
nedis data | 2 |
even within | 2 |
taking additional | 2 |
nitric dioxide | 2 |
individual actions | 2 |
language concordance | 2 |
fold higher | 2 |
designed studies | 2 |
reliably afford | 2 |
initial ingested | 2 |
provide cpr | 2 |
highly suspicious | 2 |
several potential | 2 |
dependent effect | 2 |
orotracheal intubation | 2 |
medrxiv database | 2 |
receptor blockade | 2 |
causing extravascular | 2 |
traumatic growth | 2 |
oral intake | 2 |
jlp lb | 2 |
protective clothing | 2 |
adrenergic blockade | 2 |
wide publicity | 2 |
injury ideally | 2 |
baseline severity | 2 |
animal reservoir | 2 |
heparin treatment | 2 |
diagnostic test | 2 |
ultimately diagnosed | 2 |
reproduction number | 2 |
chloroquine overdose | 2 |
aminoquinolinerelated nausea | 2 |
dose cq | 2 |
using i | 2 |
referral hospitals | 2 |
hospitalized covid | 2 |
immediate endotracheal | 2 |
eight hours | 2 |
acute physiology | 2 |
care patients | 2 |
greater degree | 2 |
ecg changes | 2 |
papr interfered | 2 |
nm bfsl | 2 |
oxide abuse | 2 |
one agent | 2 |
significant hypokalemia | 2 |
gastric irritant | 2 |
high distinguishing | 2 |
complaints warranting | 2 |
significantly reduce | 2 |
using stata | 2 |
av block | 2 |
pcr positivity | 2 |
sections describe | 2 |
academic ed | 2 |
high oral | 2 |
requires training | 2 |
systolic dysfunction | 2 |
flow therapy | 2 |
return visit | 2 |
likert scale | 2 |
established lethal | 2 |
nursing procedures | 2 |
continued exposure | 2 |
cardiovascular system | 2 |
increased cfr | 2 |
ed admission | 2 |
mg hr | 2 |
reservoir masks | 2 |
also significantly | 2 |
min rest | 2 |
ef seem | 2 |
waiting area | 2 |
ophthalmologic sequelae | 2 |
global surveillance | 2 |
volume urban | 2 |
jupiter powered | 2 |
health systems | 2 |
essential medical | 2 |
proven protease | 2 |
via different | 2 |
family member | 2 |
google scholar | 2 |
inspired concentration | 2 |
participants responded | 2 |
weight may | 2 |
day ten | 2 |
severe medical | 2 |
support device | 2 |
previous year | 2 |
minimal change | 2 |
availability issue | 2 |
wearing personal | 2 |
swpf values | 2 |
ji jz | 2 |
care clinical | 2 |
received either | 2 |
specific guidelines | 2 |
spontaneous breathing | 2 |
chloroquine produces | 2 |
evidence suggests | 2 |
inflammatory mediators | 2 |
without azithromycin | 2 |
prompts early | 2 |
collect data | 2 |
medical comorbidities | 2 |
prognostic value | 2 |
cellular receptor | 2 |
survival versus | 2 |
mucous membranes | 2 |
latinx community | 2 |
treating patients | 2 |
migraine attacks | 2 |
immunodeficiency virus | 2 |
positioned patient | 2 |
higher dose | 2 |
min seob | 2 |
despite slight | 2 |
data favor | 2 |
three bouts | 2 |
nasal congestion | 2 |
announces two | 2 |
assist physicians | 2 |
previously mentioned | 2 |
findings detailed | 2 |
bnp levels | 2 |
drug binds | 2 |
antibody testing | 2 |
insufficient power | 2 |
sore throat | 2 |
now available | 2 |
anticipated surge | 2 |
nasopharyngeal samples | 2 |
kimberly clark | 2 |
higher proportion | 2 |
hypoxemic patients | 2 |
first five | 2 |
toxicity ranging | 2 |
damage via | 2 |
prochlorperazine mg | 2 |
patient received | 2 |
underlying toxicity | 2 |
global disease | 2 |
plastic surgery | 2 |
experiencing ventricular | 2 |
first intubation | 2 |
wear ppe | 2 |
plasminogen activator | 2 |
study middle | 2 |
responses compared | 2 |
worsen conduction | 2 |
among physicians | 2 |
regarding reverse | 2 |
identify racial | 2 |
benzodiazepine may | 2 |
iii antiarrhythmics | 2 |
minimize contact | 2 |
major trajectories | 2 |
qrs prolongation | 2 |
beyond epinephrine | 2 |
multivariate logistic | 2 |
muscle toxicity | 2 |
channel inhibition | 2 |
toxicity resolves | 2 |
designated registration | 2 |
recent reports | 2 |
working group | 2 |
aminoquinolines produce | 2 |
francisco mission | 2 |
factors may | 2 |
infection risk | 2 |
failure requiring | 2 |
knowledge infrastructure | 2 |
different chief | 2 |
general may | 2 |
accurate compared | 2 |
treating physician | 2 |
previous experience | 2 |
suspected patients | 2 |
early mechanical | 2 |
following keywords | 2 |
patients experiencing | 2 |
condition without | 2 |
psychiatric care | 2 |
also showed | 2 |
include lack | 2 |
disseminated intravascular | 2 |
alt elevations | 2 |
ritonavir mg | 2 |
toxic derivative | 2 |
hemodialysis use | 2 |
hours may | 2 |
mcg ml | 2 |
refractory period | 2 |
eye maculopathy | 2 |
motor examination | 2 |
may delay | 2 |
mental illness | 2 |
chronic aminoquinoline | 2 |
adequately designed | 2 |
preventative actions | 2 |
medical toxicologist | 2 |
posterior spinal | 2 |
qt syndromes | 2 |
patients will | 2 |
also used | 2 |
recovery time | 2 |
rv zw | 2 |
informing hospital | 2 |
lupus anticoagulant | 2 |
virus infections | 2 |
media accounts | 2 |
iv nsaids | 2 |
ten patients | 2 |
conduction disorders | 2 |
low doses | 2 |
laboratory results | 2 |
nasopharyngeal swabs | 2 |
different patient | 2 |
antidysrhythmic effect | 2 |
animal source | 2 |
health disparities | 2 |
daily average | 2 |
laboratory findings | 2 |
publication elsewhere | 2 |
air turbo | 2 |
reported ast | 2 |
intubation analgesia | 2 |
us emergency | 2 |
disease course | 2 |
kg lean | 2 |
spine table | 2 |
initial stages | 2 |
outcome achievement | 2 |
based niv | 2 |
cumulative mortality | 2 |
approximately ft | 2 |
registry analysis | 2 |
data may | 2 |
angiotensin i | 2 |
team safety | 2 |
therapy may | 2 |
timely treatment | 2 |
appropriate isolation | 2 |
potential implications | 2 |
possible sars | 2 |
disease prevalence | 2 |
registration desk | 2 |
chronic therapeutic | 2 |
drug interactions | 2 |
integrating prophylactic | 2 |
ten days | 2 |
patients receiving | 2 |
medical equipment | 2 |
terminate dysrhythmias | 2 |
intracellular organelles | 2 |
larger cohort | 2 |
investigation team | 2 |
early following | 2 |
treated symptomatically | 2 |
medical toxicologists | 2 |
risk stratification | 2 |
abnormalities plasma | 2 |
despite cessation | 2 |
difficulty breathing | 2 |
vary inversely | 2 |
many untreated | 2 |
expert opinion | 2 |
pm concentration | 2 |
infection may | 2 |
dyskinetic interventricular | 2 |
vision recovery | 2 |
frequently used | 2 |
promising results | 2 |
outbreak following | 2 |
mortality associated | 2 |
improvement within | 2 |
male adult | 2 |
may perform | 2 |
nested case | 2 |
examine racial | 2 |
emergency services | 2 |
care use | 2 |
protecting factor | 2 |
hcws due | 2 |
cause aerosolization | 2 |
nyc hospital | 2 |
workshop summary | 2 |
healthy year | 2 |
immune dysregulation | 2 |
via alterations | 2 |
low cost | 2 |